Overview
Status
Active
Registry date
2023-10-17
Share capital
50,000.00 PLN
Registered address
Plac Stanisława Małachowskiego 2, 00-066 Warszawa, Poland
Electronic delivery address
AE:PL-95799-40113-IEITR-18
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. Spółka jest w procesie likwidacji
From the notes
| Profit allocation | No decision | |
| Related parties | 1 items | |
| Parent company | PHARMAAND GMBH |
Filing timeliness
The financial statement for 2024 was filed on time.
- 2025filed
- 202416/05/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Voivodeship · Mazowieckie108,761 / 142,033
Top 77%
Country · Poland388,822 / 495,860
Top 78%
Results vs industry
Revenue
This companyUSD 17.84kMedianUSD 115.65kAverageUSD 1.11m
Net profit
This companyUSD 1.27kMedianUSD 4.00kAverageUSD 74.64k
Operating costs
This companyUSD 15.95kMedianUSD 100.66kAverageUSD 1.01m
Assets
This companyUSD 122.42kMedianUSD 57.29kAverageUSD 667.46k
Industry
Authorized Representatives
Sławomir Karasiński – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Pharmaand Gmbh | 1,000 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-12-01.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Aug 28, 2025 | Liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aqirosp. z o.o. | $19,038.08 | aqiro.pl | ||
| Sedatosp. z o.o. | $18,660.07 | sedato.pl | ||
| Narodowy Instytut Rozwoju Przedsiębiorczościsp. z o.o. | $19,474.12 | nirp.pl | ||
| Cloudly Studiosp. z o.o. | $18,128.19 | cloudly.studio | ||
| Moby Dick Co.sp. z o.o. | $17,907.72 | mobydick.co | ||
| Injoysp. z o.o. | $17,772.48 | injoy.pl | ||
| M-22sp. z o.o. | $16,929.97 | m22.pl | ||
| Bezpieczna-Reklama.Plsp. z o.o. | $16,314.16 | bezpieczna-reklama.pl | ||
| Warszawska Grupa Mediowasp. z o.o. | $14,975.52 | warszawskagm.pl | ||
| Citypromotion Antolaksp. k. | $14,332.37 | citypromotion.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-08 | Address change (Rondo Ignacego Daszyńskiego 1, 00-843, Warszawa → Plac Stanisława Małachowskiego 2, 00-066, Warszawa) | |
| 2025-09-08 | Name change (Pharma& Polska → Pharma& Polska Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2025-08-13 | Liquidation opened | |
| 2024-02-14 | Share capital increase (5,000.00 PLN → 50,000.00 PLN) | |
| 2024-01-09 | Address change (Plac Stanisława Małachowskiego 2, 00-066, Warszawa → Rondo Ignacego Daszyńskiego 1, 00-843, Warszawa) |
FAQ
The main business activity of Pharma& Polska focuses on advertising agencies.
The company was registered in the Polish National Court Register (KRS) on October 17, 2023.
The headquarters is located at: Plac Stanisława Małachowskiego 2, 00-066 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from August 13, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $17,843, representing a decrease of 97.6% compared to 2024.
Yes, the company recorded a net profit of $1,271 in 2025, meaning the company decreased its profit by 96.3%.
The largest operating cost category falls under external services. This category amounted to $15,952 in 2025, representing 100% of all operating expenses.
Last updated: 2026-10-07